Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      • Home
      • Farhat Nasim

      Articles By : Farhat Nasim

      Glyphosate Case: Bayer to comply with court mediation order

      Glyphosate Case: Bayer to comply with court mediation order

      Farhat Nasim14 April 2019 9:20 AM IST
      FRANKFURT: Bayer said on Friday it would comply with a U.S. federal judge’s order to enter mediation with a plaintiff who claims the company failed to...
      JnJ gets USFDA nod to Balversa for treating bladder cancer

      JnJ gets USFDA nod to Balversa for treating bladder cancer

      Farhat Nasim13 April 2019 12:06 PM IST
      Balversa, developed by JnJ is the first approved drug in a class known as FGFR inhibitors that targets growth factor receptors involved in cell growth...
      Tamil Nadu: Pharmacist stabbed to death inside Sivaganga Medical College Hospital

      Tamil Nadu: Pharmacist stabbed to death inside Sivaganga Medical College Hospital

      Farhat Nasim13 April 2019 9:45 AM IST
      Sivaganga: In an unfortunate incident, a pharmacist who worked in the Sivaganga Medical College Hospital was brutally stabbed to death by a youth. The...
      Sandoz to commercialize Rizmoic to treat opioid-induced constipation

      Sandoz to commercialize Rizmoic to treat opioid-induced constipation

      Farhat Nasim13 April 2019 9:21 AM IST
      HOLZKIRCHEN: Sandoz recently announces that it has signed an agreement with Shionogi & Co Ltd for commercialization of Rizmoic (naldemedine) in...
      Cipla launches respiratory inhalation therapy product Niveoli in India

      Cipla launches respiratory inhalation therapy product Niveoli in India

      Farhat Nasim12 April 2019 11:41 AM IST
      New Delhi: Drug major Cipla Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India. Niveoli is used...
      Lupin receives USFDA approval for Testosterone Gel

      Lupin receives USFDA approval for Testosterone Gel

      Farhat Nasim11 April 2019 5:28 PM IST
      The company has received approval from the United States Food and Drug Administration (USFDA) to market its generic testosterone gel, 1.62 per cent...
      Wockhardt gets USFDA nod for Decitabine injection to treat cancer

      Wockhardt gets USFDA nod for Decitabine injection to treat cancer

      Farhat Nasim11 April 2019 9:15 AM IST
      Wockhardt will launch Decitabine injection in the US in a short period of time.New Delhi: Pharma major Wockhardt Wednesday said it has received...
      Sanofi to cut cost of some insulin products to $99 per month

      Sanofi to cut cost of some insulin products to $99 per month

      Farhat Nasim11 April 2019 9:10 AM IST
      Under its plan, Sanofi said people with diabetes in the United States can buy up to 10 boxes of insulin pens or vials with a valid prescription for...
      Lupin launches antidepressant drug Fluoxetine in US market

      Lupin launches antidepressant drug Fluoxetine in US market

      Farhat Nasim10 April 2019 10:35 AM IST
      The company has launched its Fluoxetine tablets USP in the strength of 60mg after having received approval from the United States Food and Drug...
      Amgen gets USFDA nod to Evenity for treating postmenopausal osteoporosis

      Amgen gets USFDA nod to Evenity for treating postmenopausal osteoporosis

      Farhat Nasim10 April 2019 9:55 AM IST
      Evenity, which belongs to a new class of drugs known as sclerostin inhibitors, is administered with two 105 mg injections every month for a year,...
      Sun Pharma launches cancer drug INFUGEM in US market

      Sun Pharma launches cancer drug INFUGEM in US market

      Farhat Nasim9 April 2019 10:05 AM IST
      Sun Pharma said INFUGEM uses its proprietary technology which allows cytotoxic oncology products to be premixed in a sterile environment and supplied...
      Torrent Pharma gets USFDA observations for Dahej plant

      Torrent Pharma gets USFDA observations for Dahej plant

      Farhat Nasim9 April 2019 9:30 AM IST
      Torrent Pharma announced that the audit at Dahej plant in Gujarat was carried out by US Food and Drug Administration (USFDA) in March 2019. New Delhi:...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok